2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $875M | $1.4B | $1.3B | $992M | $1.1B |
Cost of Revenue | $478M | $746M | $717M | $516M | $521M |
Gross Profit | $397M | $656M | $597M | $477M | $531M |
Gross Profit % | 45% | 47% | 45% | 48% | 50% |
R&D Expenses | $20M | $23M | $22M | $25M | $26M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $43M | $204M | $179M | $81M | $119M |
Dep. & Amort. | $63M | $58M | $58M | $53M | $56M |
Def. Tax | -$300K | -$15M | -$5.3M | -$13M | -$11M |
Stock Comp. | $1.9M | $15M | $7.9M | $9.2M | $11M |
Chg. in WC | $99M | -$98M | -$135M | $43M | $29M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $115M | $266M | $56M | $178M | $197M |
ST Investments | $0 | $0 | $0 | $25M | $0 |
Cash & ST Inv. | $115M | $266M | $56M | $203M | $197M |
Receivables | $140M | $208M | $236M | $281M | $279M |
Inventory | $145M | $233M | $284M | $215M | $216M |
Hayward reported strong Q4 2024 results, with net sales increasing 17% year-over-year to $327 million, driven by a 12% volume increase, 4% positive pricing, and contributions from the Clorking acquisition.
Full-year 2024 net sales grew 6% to $1.05 billion, with adjusted EBITDA up 12% to $277 million and gross profit margins exceeding 50% for the first time on a full-year basis.
For fiscal year 2025, Hayward expects net sales growth of 1%-5% ($1.06-$1.1 billion) and adjusted EBITDA of $280-$290 million, with a focus on modest volume growth and a 2%-3% positive price contribution.
The company highlighted operational improvements, including SKU rationalization, manufacturing consolidation in Europe, and investments in R&D and customer care, which are expected to drive long-term margin expansion and efficiency.
Hayward reduced net leverage to 2.8x adjusted EBITDA in 2024, improved working capital metrics, and generated free cash flow of $188 million, representing a 22% increase year-over-year.